Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy-Reference-Cited by-同舟云学术

Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy

Published:2009-04-24 Issue:2 Volume:38 Page:179-186
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Mantovani G.,Coiana A.,Massidda A.,Locci F.,Loy M.,Piludu G.,Piras M. C.,Macció A.,Giacco G. S.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1987.tb01159.x/fullpdf

Reference32 articles.

1. The functional relationship of the interleukins;Smith;J Exp Med,1980

2. Human T lymphocyte growth factor: Regulation of growth and function of T lymphocytes;Ruscetti;Blood,1981

3. T cell growth factor receptors. Quantitation, specificity and biological relevance;Robb;J Exp Med,1981

4. The interleukin-2 T-cell system: a new cell growth model;Cantrell;Science,1984

5. Cell-mediated immune deficiency in Hodgkin's disease;Kumar;Immunol Today,1982

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides and polypeptides as modulators of the immune response: thymopentin — an example with unknown mode of action;Pharmaceutica Acta Helvetiae;1999-06

2. Serum levels of interleukin-2 receptor (CD 25) in patients with Hodgkin's disease, with special reference to age and prognosis;Annals of Oncology;1995-01

3. Hodgkin's Disease in Young and Elderly Patients. Clinical and Pathological Studies;Upsala Journal of Medical Sciences;1994-01

4. Cytofluorimetric analysis of mitogen-activated peripheral blood lymphocytes of non-leukemic lymphoma patients reveals an abnormal disease-related expression pattern of activation antigens;Journal of Cancer Research and Clinical Oncology;1990-11

5. Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro;Cancer;1990-08-15